Multisite Virtual Reality Intervention for Speech Anxiety
Exposure-based cognitive behavior therapy is an efficacious treatment for speech anxiety and has been delivered effectively in a virtual reality (VR) environment. The present multicenter study (conducted through the Exposure Therapy Consortium) is designed to evaluate whether trait versus state positive affectivity is a more effective predictor of exposure therapy outcomes. Further, the investigators will examine whether the predictive significance of trait positive affectivity can be accounted for by examination of baseline levels of self-efficacy, hope, and optimism.
Study details:
The goal of this multicenter clinical trial is to examine predictors of VR exposure therapy outcomes for college students with public speaking anxiety following a positive or negative mood induction. The overarching aim of the present study is to evaluate whether trait versus state positive affectivity is a more effective predictor of exposure therapy outcomes. Further, the investigators will examine whether the predictive significance of trait positive affectivity can be accounted for by examination of baseline levels of self-efficacy, hope, and optimism.
State affect is manipulated at an experimental level with affect induction procedures; trait positive affectivity is measured at baseline. The study involves three phases: (1) initial screening, (2) in-person assessment and brief exposure intervention for a subset of participants with elevated public speaking anxiety, and (3) a one-week follow-up assessment conducted online. Students who choose to participate and screen high on a public speaking anxiety scale will be assigned to a positive or negative mood induction condition prior to undergoing VR-based exposure therapy.
Public speaking and social anxiety outcomes are measured immediately post-intervention and one week later. The one-week follow-up assessment represents the primary outcome.
Eligibility criteria
Researchers look for people who fit a certain description, called eligibility criteria. See if you qualify.
Inclusion criteria
- Self-report of 18 - 70 years of age
- Current student at a participating University
- Ability to read English to provide informed consent
- Familiarity with a computer keyboard and mouse or a touch screen device (e.g. phone, tablet).
- For Phase 2: speech anxiety scale score of ≥ 18 on the Personal Report of Communication Apprehension, Public Speaking Subscale (PRCA-PS)
Exclusion criteria
- Previous participation (i.e., no participant may take the survey more than once).
Eligibility
Age eligible for study : NA
Healthy volunteers accepted : No
Gender eligible for study: ALL
Things to know
Study dates
Study start:
Primary completion:
Study completion finish:
Study type
TREATMENT
Phase
- NA
Study ID
NCT06593847
Intervention or treatment
BEHAVIORAL: Single-session VR exposure intervention
Conditions
- Public Speaking
- Speech Anxiety
You may be eligible to participate in this trial based on your search. Check eligibility by answering some questions.
Research sites nearby
Closest Location:
Western Sydney University
Select from list below to view details:
Western Sydney University
Penrith, New South Wales, Australia
University of New South Wales
Sydney, New South Wales, Australia
Curtin University
Bently, Western Australia, Australia
Loading map...
Who is running the clinical trial?
Boston University Charles River Campus
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
| Participant Group/Arm | Intervention/Treatment |
|---|---|
OTHER: Positive or Negative Mood Induction via film clips
| Behavioral: Single-session VR exposure intervention |
What is the study measuring?
Primary Outcome
| Measure | Description | Time Frame |
|---|---|---|
| Public Speaking Anxiety | Assessed using the Personal Report of Communication Apprehension, Public Speaking Subscale (PRCA-PS). Scores range from 6 to 30, with higher scores associated with higher public speaking anxiety. | One week follow-up assessment |
Secondary Outcome
| Measure | Description | Time Frame |
|---|---|---|
| Valence | Self-report measure of how participant feels about having to give a speech | One week follow-up assessment |
| Assessed using the Social Phobia Inventory (SPIN) | Assessed using the Social Phobia Inventory (SPIN). Scores range from 0-68, with higher scores indicating greater social phobia. | One week follow-up assessment |
| Public Speaking Anxiety | Assessed using the Personal Report of Communication Apprehension, Public Speaking Subscale (PRCA-PS). Scores range from 6 to 30, with higher scores associated with higher public speaking anxiety. | Post-treatment assessment immediately after the intervention |
References
Clinical Trials Gov: Multisite Virtual Reality Intervention for Speech AnxietyOther trials to consider
Loading suggested trials...
